Anthem Biosciences IPO Overview
Anthem Biosciences is a research-driven drug manufacturer set to launch its IPO for subscription on July 14. The IPO price band is set between Rs 540 to Rs 570 per share.
Key Dates and Details
The IPO will open on July 14 and close on July 16, with shares set to hit the market on July 21. Investors can apply for shares in lots of 26 with a minimum investment of Rs 14,820.
IPO Details and Reservation
The IPO is an offer for sale worth Rs 3,395.00 crore and has set aside quotas for different types of investors. The issue is managed by JM Financial Ltd, Citigroup Global Markets India, J P Morgan India, and Nomura Financial Advisory and Securities.
Financials and GMP
Anthem Biosciences has seen revenue and profit growth. The grey market premium is currently +100, indicating strong investor interest.
For more information, you can visit NDTV Profit and investorain.com.
Full article link in bio
📌 Also Read:
- Tesla’s Expansion in Mumbai: New Showrooms and Offices Revealed – GNP News
- BHEL Artisan Recruitment 2025: Apply for 515 Posts at careers.bhel.in – GNP News
- XAI Holdings Seeks $20 Billion in New Funding Round – GNP News